AUG 1, 2026 · JOURNAL ARTICLE
Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: findings from the MoKaRi trial
Journal of Clinical Lipidology
A well-designed 20-week RCT with a responsive surrogate biomarker endpoint (CERT2 score) showing statistically significant reductions with fish oil plus diet, but lacking hard clinical outcomes and requiring confirmation in larger populations.
Reported
CERT2 score reduction (MP-FO vs M…-2.44 (95% CI -3.42 to -1.47)
CERT2 score reduction (MP-FO vs M…-2.18 (95% CI -3.15 to -1.21)
CERT2 score reduction (MP-FO vs M…-1.63 (95% CI -2.61 to -0.65)